NIH has awarded a five-year, $4.63 million grant to NYU College of Dentistry researchers to study chemotherapy-induced painful peripheral neuropathy, or CIPPN.
For over a month since President Trump announced his intent to impose aggressive new tariffs on America’s friends and foes alike, lobbyists for hospitals, medical societies, and makers of branded and generic drugs have been trying to convince him to rethink.
